The IPO activity in the U.S. pharma/biotech sector had a strong showing last quarter (Q2) with 24 listings compared to 13 in the year-ago period. There has not been a single biotech IPO for the month of July so far. But that is about to change.
from RTT - Biotech https://ift.tt/2mmcHHe
via IFTTT
No comments:
Post a Comment